Diagnosis and treatment strategies of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antiviral drugs

VernacularTitle:直接抗病毒药物时代丙型肝炎病毒相关肝细胞癌的诊治对策
Author: Xu GAO ¹ ; Fanpu JI
Author Information

1. 西安交通大学第二附属医院感染科　710004
Keywords: Chronic hepatitis C; Hepatocellular carcinoma; Direct-acting antiviral agents; Diagnosis and treatment strategy
From: Chinese Journal of Hepatology 2020;28(10):827-830
CountryChina
Language:Chinese
Abstract: The occult progression of chronic hepatitis C (CHC) is one of the main causes of liver cirrhosis and hepatocellular carcinoma (HCC). Recently, antiviral treatment of CHC has achieved great progress with the advent of direct-acting antiviral drugs (DAA), especially for special populations including advanced liver disease and HCC. However, DAA and HCC-related issues have also become one of the important concerns of current CHC treatment. This article summarizes the recent research progresses made in the diagnosis and treatment of HCV-related HCC.